These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 11905954)
41. Soybean isoflavones in bone health. Ishimi Y Forum Nutr; 2009; 61():104-116. PubMed ID: 19367115 [TBL] [Abstract][Full Text] [Related]
42. Decreased growth of human prostate LNCaP tumors in SCID mice fed a low-fat, soy protein diet with isoflavones. Aronson WJ; Tymchuk CN; Elashoff RM; McBride WH; McLean C; Wang H; Heber D Nutr Cancer; 1999; 35(2):130-6. PubMed ID: 10693166 [TBL] [Abstract][Full Text] [Related]
43. Beyond the Cholesterol-Lowering Effect of Soy Protein: A Review of the Effects of Dietary Soy and Its Constituents on Risk Factors for Cardiovascular Disease. Ramdath DD; Padhi EM; Sarfaraz S; Renwick S; Duncan AM Nutrients; 2017 Mar; 9(4):. PubMed ID: 28338639 [TBL] [Abstract][Full Text] [Related]
44. Soyfoods and soybean phyto-oestrogens (isoflavones) as possible alternatives to hormone replacement therapy (HRT). Messina M Eur J Cancer; 2000 Sep; 36 Suppl 4():S71-2. PubMed ID: 11056326 [No Abstract] [Full Text] [Related]
45. Soy induces phase II enzymes but does not inhibit dimethylbenz[a]anthracene-induced carcinogenesis in female rats. Appelt LC; Reicks MM J Nutr; 1999 Oct; 129(10):1820-6. PubMed ID: 10498753 [TBL] [Abstract][Full Text] [Related]
46. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Alekel DL; Germain AS; Peterson CT; Hanson KB; Stewart JW; Toda T Am J Clin Nutr; 2000 Sep; 72(3):844-52. PubMed ID: 10966908 [TBL] [Abstract][Full Text] [Related]
47. Natural and synthetic isoflavones in the prevention and treatment of chronic diseases. Brandi ML Calcif Tissue Int; 1997; 61 Suppl 1():S5-8. PubMed ID: 9263608 [TBL] [Abstract][Full Text] [Related]
48. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. Kreijkamp-Kaspers S; Kok L; Grobbee DE; de Haan EH; Aleman A; Lampe JW; van der Schouw YT JAMA; 2004 Jul; 292(1):65-74. PubMed ID: 15238592 [TBL] [Abstract][Full Text] [Related]
49. Soy protein with or without isoflavones: in search of a cardioprotective mechanism of action. Kris-Etherton PM; West SG Am J Clin Nutr; 2005 Jan; 81(1):5-6. PubMed ID: 15640453 [No Abstract] [Full Text] [Related]
51. Soy protein with or without isoflavones failed to preserve bone density in gonadal hormone-deficient male rat model of osteoporosis. Juma SS; Ezzat-Zadeh Z; Khalil DA; Hooshmand S; Akhter M; Arjmandi BH Nutr Res; 2012 Sep; 32(9):694-700. PubMed ID: 23084642 [TBL] [Abstract][Full Text] [Related]
52. Soy isoflavones for postmenopausal symptoms. An examination of evidence. Hulem R; Blair RM Adv Nurse Pract; 2006 May; 14(5):32-8; quiz 39. PubMed ID: 16972423 [No Abstract] [Full Text] [Related]
53. Snack bars with high soy protein and isoflavone content for use in diets to control dyslipidaemia. Lobato LP; Iakmiu Camargo Pereira AE; Lazaretti MM; Barbosa DS; Carreira CM; Mandarino JM; Grossmann MV Int J Food Sci Nutr; 2012 Feb; 63(1):49-58. PubMed ID: 21728920 [TBL] [Abstract][Full Text] [Related]
54. Removing isoflavones from modern soyfood: Why and how? Fernandez-Lopez A; Lamothe V; Delample M; Denayrolles M; Bennetau-Pelissero C Food Chem; 2016 Nov; 210():286-94. PubMed ID: 27211649 [TBL] [Abstract][Full Text] [Related]
55. Dietary isoflavones and vascular protection: activation of cellular antioxidant defenses by SERMs or hormesis? Siow RC; Mann GE Mol Aspects Med; 2010 Dec; 31(6):468-77. PubMed ID: 20837051 [TBL] [Abstract][Full Text] [Related]
56. Effects on the human serum lipoprotein profile of beta-glucan, soy protein and isoflavones, plant sterols and stanols, garlic and tocotrienols. Kerckhoffs DA; Brouns F; Hornstra G; Mensink RP J Nutr; 2002 Sep; 132(9):2494-505. PubMed ID: 12221200 [TBL] [Abstract][Full Text] [Related]
57. Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: a double-blind, randomized, placebo-controlled trial. Ho SC; Chen YM; Ho SS; Woo JL Menopause; 2007; 14(5):905-12. PubMed ID: 17413839 [TBL] [Abstract][Full Text] [Related]
58. Risks and benefits of dietary isoflavones for cancer. Andres S; Abraham K; Appel KE; Lampen A Crit Rev Toxicol; 2011 Jul; 41(6):463-506. PubMed ID: 21438720 [TBL] [Abstract][Full Text] [Related]
59. A cooperative interaction between soy protein and its isoflavone-enriched fraction lowers hepatic lipids in male obese Zucker rats and reduces blood platelet sensitivity in male Sprague-Dawley rats. Peluso MR; Winters TA; Shanahan MF; Banz WJ J Nutr; 2000 Sep; 130(9):2333-42. PubMed ID: 10958832 [TBL] [Abstract][Full Text] [Related]
60. WHI and WHIMS follow-up and human studies of soy isoflavones on cognition. Zhao L; Brinton RD Expert Rev Neurother; 2007 Nov; 7(11):1549-64. PubMed ID: 17997703 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]